P
PLX
vs
EXAS
EXAS
Over the past 12 months, PLX has underperformed EXAS, delivering a return of -5% compared to the EXAS's +4 091% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
EXAS
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
2.28
USD
|
|||||
|
Exact Sciences Corp
NASDAQ:EXAS
|
1 862.99
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
PLX, EXAS
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
P
|
Protalix Biotherapeutics Inc
Revenue
|
|||||||||||
|
Exact Sciences Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
PLX, EXAS
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
|||||||||
|
Exact Sciences Corp
NASDAQ:EXAS
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
P
|
Protalix Biotherapeutics Inc | ||||
|
Exact Sciences Corp | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
P
|
Protalix Biotherapeutics Inc | ||||
|
Exact Sciences Corp | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
P
|
Protalix Biotherapeutics Inc | ||||
|
Exact Sciences Corp | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
P
|
Protalix Biotherapeutics Inc | ||||
|
Exact Sciences Corp | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
P
|
Protalix Biotherapeutics Inc | ||||
|
Exact Sciences Corp | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
P
|
Protalix Biotherapeutics Inc | ||||
|
Exact Sciences Corp | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
P
|
Protalix Biotherapeutics Inc | ||||
|
Exact Sciences Corp | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
P
|
Protalix Biotherapeutics Inc | ||||
|
Exact Sciences Corp | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
PLX, EXAS
Performance Gap
PLX, EXAS
Performance By Year
PLX, EXAS
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
S
|
Seagen Inc
F:SGT
|